Next Generation Vaccine Development with Proteomics
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
July 2022
May 2022
Enriching Engineered T Cells with Antibody Sequencing & Modulation
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
April 2022
Identifying CDRs by Antibody Sequencing
Contents What are CDRs? Antibody CDRs De Novo Protein Sequencing as a Tool for Identifying CDRs sequences Applying De Novo Protein Sequencing to Identify CDRs Sequences Annotation schemes for identifying CDRs by Sequence Rapid Novor can Help with Identifying CDRs by Sequence What are CDRs? The acronym “CDR” stands [...]
March 2022
Breakthrough Bispecific Antibody R&D Techniques
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
First Immunoassay for Measuring Isoaspartate in Human Serum Albumin
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
Sequencing and Recombinant Expression of Goat Antibodies from a Polyclonal Mixture
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
February 2022
Species Agnostic Antibody Sequencing & Discovery in Veterinary Medicine R&D
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
Why Antibody Characterization Needs An Overhaul
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
Leveraging the Power of Next Generation Protein Sequencing to Shape Tomorrow’s In Vitro Diagnostics
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
January 2022
Recombinant Therapeutic pAbs are Now Possible
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
December 2021
Polyclonal Antibody Sequencing in Therapeutics Development Pipelines
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
November 2021
In-Depth Characterization of Monoclonal Antibodies with a Single Experiment and Fully Automated Data Analysis
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
October 2021
What is Peptide Mapping?
Peptide mapping is a widely used analytical technique to verify the primary structure (amino acid sequence) and characterize the chemical modifications of a protein. It analyzes peptides generated from the digestion of an isolated protein, or a protein mixture
September 2021
Overcoming Irreproducibility in Life Science Research
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
July 2021
Fully Harnessing the Power of Immunotherapy through Protein Sequencing
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
DNA vs Next Gen Protein Sequencing – a Deep Dive
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
May 2021
Polyclonal Antibody Sequencing with Only Proteomics
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
April 2021
Non-Fungible Antibodies
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
Leveraging pAbs for Therapeutic Development
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
March 2021
Leveraging Polyclonal Antibody Sequencing to Get High Affinity Binders Against Tough Targets
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
January 2021
Antibody Sequencing as a Tool to Improve Reproducibility in the Life Sciences
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
November 2020
New Era in Anti-Drug Antibody Assays
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
October 2020
Research Insurance with de novo Protein Sequencing
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
September 2020
Leveraging Recombinant Patient Antibodies in Therapeutic Applications
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
May 2020
Introduction to de novo Protein Sequencing
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
April 2019
Antibody Characterization by Mass Spectrometry
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications